Søren Hostrup

Søren Hostrup has a diverse work experience spanning over several companies and roles. Søren started their career as a Government Official at the Danish Ministry of Taxation in 1997 and then transitioned into the legal field as an Attorney-at-law at Bech-Bruun Law Firm in 2001. In 2002, they worked as a Teacher at Copenhagen University before joining Novo Nordisk A/S as a Corporate Counsel in 2005. Søren then moved to DONG Energy A/S as an Attorney-at-law in 2006. Søren joined Xellia Pharmaceuticals in 2008 as the Director for "Commercial Legal" and held this position for ten years before becoming their International General Counsel until 2021. From 2021 to 2023, Søren served as the Group General Counsel and Vice President of Xellia Pharmaceuticals before becoming the Chief Legal Officer and Vice President, their current role. Søren has a strong legal background, including expertise in life science, intellectual property, legal compliance, and commercial litigation.

Søren Hostrup completed their education with a Graduate Diploma in Business Administration from Copenhagen Business School in 2001. Prior to that, they obtained a degree in Law, specifically Cand. jur., from the University of Copenhagen between 1992 and 1997. Their earlier education included studying at Albertslund Amtsgymnasium from 1989 to 1992, although the specific degree or field of study is not provided.